xCures
Kenny Wong has extensive experience in the field of genetics and healthcare, with a focus on product management and advisory roles. Kenny is currently serving as the Chief Product Officer at xCures since 2020. Prior to that, they held positions at National Society of Genetic Counselors, Carmentix Pte Ltd, noHold Inc., Northern California Coalition of Genetic Counselors, Myriad Genetics, Access to Expanded Carrier Screening Coalition, GenomeSmart Inc, Counsyl, and Counsyl (acquired by Myriad Genetics). In these roles, Kenny has demonstrated their expertise in strategic advisory, board membership, consulting, and product development. Kenny has also been involved in fundraising efforts and successful company acquisitions. Throughout their career, Kenny has shown a strong commitment to advancing genetic technology and enhancing patient care.
Kenny Wong's education includes a Bachelor of Science degree in Cell Biology and Genetics, which they obtained from The University of British Columbia between 2000 and 2005. Kenny later pursued a Master of Science degree in Human Genetics at Sarah Lawrence College from 2005 to 2007.
This person is not in any offices
xCures
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.